Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2014
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140335607 Methods and compositions relating to restricted expression lentiviral vectors and their applications
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/13/2014US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
11/13/2014US20140335047 Drug delivery product and methods
11/11/2014US8883996 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/11/2014US8883987 Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides
11/11/2014US8883756 SDF-1 delivery for treating ischemic tissue
11/11/2014US8883755 Mitochondrial targeted RNA expression system and use thereof
11/11/2014US8883753 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
11/11/2014US8883752 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom
11/11/2014US8883751 Composition containing microRNA-21 inhibitor for enhancing radiation sensitivity
11/11/2014US8883724 Active antiangiogenic therapy
11/11/2014US8883716 Method for treating damaged tissue of the CNS
11/11/2014US8883505 Genetic material manipulation techniques and products thereof
11/11/2014US8883493 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
11/11/2014US8883425 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/11/2014US8883208 Particles for delivery of nucleic acids and related devices and methods
11/11/2014US8883200 Delivery of nucleic acid-like compounds
11/11/2014US8883174 Compositions for stimulation of mammalian innate immune resistance to pathogens
11/11/2014US8883169 Immunogen platform
11/11/2014US8883144 Treatment of pulmonary vascular remodeling with neprilysin
11/06/2014US20140329882 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/06/2014US20140328825 MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT
11/06/2014US20140328820 Novel Class of Therapeutic Protein Based Molecules
11/04/2014US8877730 Targeting microRNAs for metabolic disorders
11/04/2014US8877729 Amino acid lipids and uses thereof
11/04/2014US8877728 Genetic changes in ATM and ATR/Chek1 as prognostic indicators in cancer
11/04/2014US8877727 Delivery of dsRNA to arthropods
11/04/2014US8877726 Method and medicament for inhibiting the expression of a given gene
11/04/2014US8877725 Peptide conjugated, inosine-substituted antisense oligomer compound and method
11/04/2014US8877724 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells
11/04/2014US8877723 Method for identification of sensitivity of a patient to telomerase inhibition therapy
11/04/2014US8877722 Compositions for inhibiting gene expression and uses thereof
11/04/2014US8877721 Small activating RNA molecules and methods of use
11/04/2014US8877448 Method of making recombinant influenza virus
11/04/2014US8877237 Reverse micelle system comprising nucleic acids and use thereof
11/04/2014US8877209 Recombinant influenza vectors with tandem transcription units
11/04/2014US8877175 Long lasting drug formulations
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140323556 Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
10/30/2014US20140323553 Methods and Compositions Related to MiR-21 & MiR-29a, Exosome Inhibition, and Cancer Metastasis
10/30/2014US20140322813 Methods and compositions for enhancing the efficacy and specificity of rna silencing
10/30/2014US20140322301 Mucin antigen vaccine
10/30/2014US20140322184 Inducible expression cassette, and uses thereof
10/30/2014US20140322181 Use of human cord blood-derived pluripotent cells for the treatment of disease
10/30/2014US20140322176 Methods of using zscan4 for rejuvenating human cells
10/28/2014US8874204 Implantable medical devices comprising isolated extracellular matrix
10/28/2014US8871748 Retinal cyclodextrin acetals and hemiacetals for treating skin complexion disorder
10/28/2014US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
10/28/2014US8871733 Treating glaucoma, cardiovascular diseases, and renal diseases
10/28/2014US8871503 Construct
10/28/2014US8871194 Method for transforming a hair follicle
10/28/2014US8871193 Viral vectors and their use in therapeutic methods
10/28/2014US8871191 Use of IL-15 preparations to treat lymphopenia
10/23/2014US20140316123 ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS
10/23/2014US20140315987 Cholecystokinin b receptor (cckbr) mini-promoters
10/23/2014US20140315978 Compositions and Methods for Treatment of Prostate and Other Cancers
10/23/2014US20140314850 Functionalized nanodiamonds as delivery platforms for nucleic acids
10/23/2014US20140314704 Treatment of B Cell Lymphomas
10/21/2014US8865884 Antisense modulation of kinesin-like 1 expression
10/21/2014US8865881 Delivery of proteins using adeno-associated virus (AAV) vectors
10/21/2014US8865677 iRNA agents with biocleavable tethers
10/21/2014US8865673 Monitoring and modulating HGF/HGFR activity
10/21/2014US8865672 Prevention of tissue ischemia and related methods
10/21/2014US8865669 DNA fragment and use thereof
10/21/2014US8865668 Methods and compositions for increasing RNA interference
10/21/2014US8865667 Higher-order cellular information processing devices
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/21/2014US8865469 Methods of transforming a Listeria
10/21/2014US8865173 Treatments for pancreatic cancer metastases
10/21/2014US8865159 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
10/21/2014US8865156 Compositions and methods for the maintenance of oral health
10/16/2014US20140309411 Therapeutic compositions
10/16/2014US20140309290 Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (cpvt)
10/16/2014US20140308312 Use of micrornas to control virus helper nucleic acids
10/16/2014US20140308255 Methods and Compositions for Regulation of Cell Aging, Carcinogenesis and Reprogramming
10/16/2014US20140308247 Vectors Conditionally Expressing Protein
10/14/2014USRE45196 Compositions comprising structurally stable conjugate molecules
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859747 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859745 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859537 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859521 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
10/14/2014US8859520 Methods for therapy of neurodegenerative disease of the brain
10/14/2014US8859519 Methods targeting miR-33 microRNAs for regulating lipid metabolism
10/14/2014US8859517 Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT)
10/14/2014US8859516 Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
10/14/2014US8859514 Modulation of C-reactive protein expression
10/14/2014US8859275 Method for modulating gene expression by modifying the CpG content
10/14/2014US8859274 Antibody fragment-targeted immunoliposomes for systemic gene delivery
10/14/2014US8859273 Methods of using HCN genes to treat cardiac arrhythmias
10/14/2014US8859208 System producing infectious recombinant influenza virus
10/14/2014US8858990 Capsule of thermogenic cells for treating a metabolic disease
10/14/2014US8858951 Compositions for eliciting an immune response
10/14/2014US8858931 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
10/14/2014US8858929 Optically sensitive cell network
10/14/2014US8858928 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 870